Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor Models

Doxorubicin (DOX) is an anthracycline widely used in cancer therapy and in particular in breast cancer treatment. The treatment with DOX appears successful, but it is limited by a severe cardiotoxicity. This work evaluated the in vitro and in vivo anticancer effect of a new formulation of β-cyclodex...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Argenziano, Monica, Gigliotti, Casimiro Luca, Clemente, Nausicaa, Boggio, Elena, Ferrara, Benedetta, Trotta, Francesco, Pizzimenti, Stefania, Barrera, Giuseppina, Boldorini, Renzo, Bessone, Federica, Dianzani, Umberto, Cavalli, Roberta, Dianzani, Chiara
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7016577/
https://ncbi.nlm.nih.gov/pubmed/31936526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12010162
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados